Sit, Rakesh Kumar,Huang, Peter Qinhua,Slee, Deborah Helen,Hegde, Sayee Gajanan,Hopkins, Chad Daniel,Bunker, Kevin Duane,Pinchman, Joseph Robert
申请号：
AU2017242027
公开号：
AU2017242027A1
申请日:
2017.03.29
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.
